Attached files

file filename
EX-99.1 - EX-99.1 - NOVELION THERAPEUTICS INC.d458788dex991.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): December 24, 2012

 

 

QLT Inc.

(Exact name of Registrant as Specified in its Charter)

 

 

 

British Columbia, Canada   000-17082   N/A
(State or other jurisdiction
of incorporation)
 

(Commission

File Number)

  (I.R.S. Employer
Identification No.)

887 Great Northern Way, Suite 101, Vancouver, B.C.

Canada, V5T 4 T5

(Address of Principal Executive Offices)

(604) 707-7000

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 8.01. Other Events.

On December 24, 2012, QLT Inc. issued a press release announcing that the Company has entered into an exclusive option agreement with Mati Therapeutics Inc. (“Mati”), a development company associated with Robert Butchofsky, QLT’s former President & CEO, under which QLT has granted Mati a 90-day option to acquire assets related to QLT’s punctal plug drug delivery system technology. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

Item 9.01. Financial Statements and Exhibits.

d) Exhibits

Pursuant to the rules and regulations of the Securities and Exchange Commission, the attached exhibit is deemed to have been furnished to, but not filed with, the Securities and Exchange Commission:

 

Number

  

Description

99.1    Press Release dated December 24, 2012


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

        QLT INC.
Date: December 24, 2012     By:  

/s/ Sukhi Jagpal

    Name:   Sukhi Jagpal
    Title:   Interim Chief Financial Officer


Exhibit Index

 

Exhibit No.

  

Description

99.1    Press Release dated December 24, 2012